How much weight can you really lose on a GLP‑1?

So many things in life sound too good to be true. They promise grand results, but the reality looks a lot different. But then there are other things that do actually live up to the hype. So where do GLP-1s fall? It kind of depends. Many people experience weight loss from taking GLP-1 medications, but results can vary from person to person. Factors such as dosage, consistency, lifestyle habits, and overall health can play a significant role. Continue reading to find out more about GLP-1 medications like semaglutide and tirzepatide, how they work, and their potential results.

GLP-1s, also known as GLP-1 receptor agonists, are medications designed to mimic action of glucagon-like peptide-1 (GLP-1), a hormone the body naturally releases after eating. GLP-1s were first prescribed to people with type 2 diabetes to stimulate the release of insulin from the pancreas and control blood sugar levels.

In recent years, certain GLP-1 treatments have been approved by the FDA for chronic weight management. They can help regulate appetite, digestion, and blood sugar by communicating a signal of fullness to the brain, which may reduce hunger and lead to weight loss. They also slow down digestion, which adds to feelings of fullness and further reduces appetite.

Several GLP-1 medications have been FDA-approved to treat diabetes or weight loss. They may share the same active ingredient, but they’re prescribed as different brands for different usages. For instance, the semaglutide for treatment of type 2 diabetes is Ozempic while the one approved for weight loss is Wegovy. And the tirzepatide for treatment of type 2 diabetes is Mounjaro while the one approved for weight loss is Zepbound.

One way researchers determine how well a specific drug works is through something called a randomized controlled trial (RCT). For GLP-1s, participants are randomly assigned to receive either the active drug or a placebo, and then their weight is tracked over time. And trials of GLP-1 receptor agonists like semaglutide and tirzepatide have shown clear efficacy in promoting weight loss when treatment is followed as prescribed. 

There’s also real-world evidence, which is taken from observational studies of people prescribed these medications in everyday clinical practice. This tends to show more variability in outcomes. In routine care, patients often use lower doses than those tested in trials and may discontinue treatment early, making overall weight loss outcomes typically smaller than those observed in RCTs. 

Weight-loss results in GLP-1 studies are usually reported either as absolute weight loss (such as pounds lost) or as relative loss from baseline weight (a percentage). 

Understanding percentages vs. pounds

A 5–10% reduction in body weight can mean different amounts of pounds. It all depends on a person’s starting weight. For example, for someone who weighs 250 pounds, a 10% reduction is 25 pounds. If you weigh 180 pounds, a 10% reduction is 18 pounds. Research on GLP-1 medications such as Zepbound and Wegovy shows that reporting outcomes as percentages or average ranges can help standardize results across individuals. This prevents any promises from being made about specific results, as weight loss can vary by individual. Clinicians encourage patients to set personalized goals and track progress over time. This way, they can focus on effective and sustainable health improvements rather than just a single number.

Although typical weight-loss results on semaglutide, tirzepatide, and other GLP-1 medications can vary, both semaglutide and tirzepatide have been seen to help provide meaningful average weight loss. Due to targeting two hormones, GLP-1 and GIP, rather than just one, tirzepatide often shows slightly greater weight reductions overall. In clinical trials, people taking semaglutide lost an average of 15% in a little over a year (even more for those taking Wegovy HD), while those on tirzepatide lost an average of 21% in roughly the same time. It’s worth noting that these findings reflect group averages rather than guaranteed outcomes, and individual responses can differ. 

These medications are prescription only, so keep in touch with your clinician, as they can provide advice and support on appropriate dosing, side-effect management, treatment expectations, and ongoing progress monitoring.

Weight loss timelines

Weight loss with GLP-1 medications generally follows a gradual, non-linear path rather than a predictable week-by-week pattern. Clinical research shows that drugs like semaglutide start working more quickly during the first few months of treatment – they can then slow over time and may reach a relative plateau later on after extended use. This reflects how the body can adapt to lower weight and regulated appetite.

Average weight loss results for GLP-1 medications are shaped by many different factors, including:

• Starting weight

• How quickly you go up in doses

• How long you stay on treatment

• Side-effect tolerance

• Health conditions

• Other medications being taken

• Supportive habits such as nutrition, adequate protein intake, exercise, quality sleep, and stress management

As weight loss results and side effects can vary, all decisions regarding dose adjustments or symptoms should be made with a qualified clinician.  

Practical strategies to support success

There are practical strategies that you can try to help support meaningful weight loss results when taking a GLP-1 drug. These include:

• Planned meals — Organizing meals in advance can help you prioritize protein, fiber, and nutrients.

• Symptom tracking — Make a note of any side effects such as nausea or changes in appetite to help you and your clinician understand how your body responds to GLP-1s. 

• Exercise — Regular physical activity, especially strength training, can help you hold on to muscle while you lose weight.

• Set reminders for doses — Use alerts to ensure you never forget to take your dose of GLP-1.

Weight-loss plateaus — pauses in your weight loss — are common during GLP-1 treatment. It doesn’t necessarily mean the medication has stopped working; it can simply be a signal that your body is adapting. In fact, plateaus often provide a useful opportunity to reassess your habits, expectations, or dosing with your clinician.

In some cases, you may also pause taking a GLP-1 due to side effects, access issues, or personal preference. When treatment stops, your appetite can increase and you may regain weight. Talk with your clinician before discontinuing your medication to have a game plan in place.

GLP-1 medications are designed to be used long-term, and ongoing lifestyle support and monitoring is important. This can include paying close attention to factors like nutrition, activity, sleep, and stress. Decisions about dose or discontinuation should be made with a qualified healthcare professional. 

Also keep in mind that weight-management GLP-1s are most effective when paired with lifestyle changes such as eating healthy foods, exercising, practicing good sleep hygiene, and keeping stress levels low. If you stop treatment without ongoing support, you may see some weight come back.

Setting goals with your clinician can help make your weight-management efforts more effective and sustainable. Start by defining personal health and quality-of-life goals that go beyond just weight loss, such as more energy, better mobility, or improved metabolic health. Choose factors that matter to you most and decide how often to check in and review progress with your clinician. Be sure to document changes in a simple log or journal too, as this can help you and your clinician spot patterns, address challenges, and adjust strategies as needed. 

What to bring to appointments

To make the most of visits with your clinician, you can bring notes on things you’ve noticed and any questions you have. For example: 

• Medication and dose history

• Symptom or side-effect log (make note of any nausea, gastrointestinal changes, etc.)

• Weekly routines (meals, activity, sleep, and stress patterns)

• Questions for your clinician regarding next steps, dose changes, or lifestyle strategies

GLP-1 medications can be an effective tool for weight management. When used appropriately and paired with supportive habits such as balanced nutrition, regular activity, quality sleep, and attention to stress levels, medications such as Wegovy and Zepbound can help you lose weight and become healthier. Ongoing support from a qualified clinician can provide dose adjustments. Lifestyle changes are also necessary to attain the best possible outcomes and help maintain long-term success.